Another Drug Shows Potential for Functional Cures in Chronic Hepatitis B

Summary
(MedPage Today) -- Reductions in hepatitis B surface antigen (HBsAg) were observed with a novel small interfering RNA (siRNA) therapy in patients with chronic hepatitis B virus (HBV) infection, according to a phase II study. Among patients randomized...
Description from Medpagetoday.
Who is covering this
-
Another Drug Shows Potential for Functional Cures in Chronic Hepatitis B
(MedPage Today) -- Reductions in hepatitis B surface antigen (HBsAg) were observed with a novel small interfering RNA (siRNA) therapy in patients with chronic hepatitis B virus (HBV) infection, according to a phase II study. Among patients randomized...
Comments
Comments need JavaScript.